abbv-383
abbvie
day 3 #ims2022 plenary abstract session nct03933735: phase 1: abbv-383 (tnb-383b) in subjects with relapsed or refractory multiple myeloma #mmsm #multiplemyeloma #curemyeloma 
Multiple Myeloma Education Platform for Myeloma Community